164 related articles for article (PubMed ID: 33825059)
41. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer.
Yang PC; Lin BR; Chen YC; Lin YL; Lai HS; Huang KW; Liang JT
Medicine (Baltimore); 2016 Apr; 95(14):e3338. PubMed ID: 27057913
[TBL] [Abstract][Full Text] [Related]
42. Reliability of Stereotactic Radiofrequency Ablation (SRFA) for Malignant Liver Tumors: Novice versus Experienced Operators.
Schullian P; Laimer G; Johnston E; Putzer D; Eberle G; Widmann G; Scharll Y; Bale R
Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829454
[TBL] [Abstract][Full Text] [Related]
43. Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience.
Huang J; Xie X; Lin J; Wang W; Zhang X; Liu M; Li X; Huang G; Liu B; Xie X
Cancer Imaging; 2019 Jun; 19(1):44. PubMed ID: 31242934
[TBL] [Abstract][Full Text] [Related]
44. Laparoscopic liver packing to protect surrounding organs during thermal ablation.
Schullian P; Weiss H; Klaus A; Widmann G; Kranewitter C; Mittermair C; Margreiter R; Bale R
Minim Invasive Ther Allied Technol; 2014 Oct; 23(5):294-301. PubMed ID: 24641527
[TBL] [Abstract][Full Text] [Related]
45. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
46. Reiterative Radiofrequency Ablation in the Management of Pediatric Patients with Hepatoblastoma Metastases to the Lung, Liver, or Bone.
Yevich S; Calandri M; Gravel G; Fresneau B; Brugières L; Valteau-Couanet D; Branchereau S; Chardot C; Aerts I; de Baere T; Tselikas L; Deschamps F
Cardiovasc Intervent Radiol; 2019 Jan; 42(1):41-47. PubMed ID: 30350173
[TBL] [Abstract][Full Text] [Related]
47. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
48. Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience.
Gonnet A; Salabert L; Roubaud G; Catena V; Brouste V; Buy X; Gross Goupil M; Ravaud A; Palussière J
BMC Cancer; 2019 Dec; 19(1):1182. PubMed ID: 31795959
[TBL] [Abstract][Full Text] [Related]
49. Clinical Effect of Percutaneous Radiofrequency Ablation for Residual Lung Metastases from Breast Cancer After Systemic Chemotherapy.
Wang Y; Lu X; Wang Y; Zhou J
J Coll Physicians Surg Pak; 2015 Aug; 25(8):602-5. PubMed ID: 26305308
[TBL] [Abstract][Full Text] [Related]
50. Retrospective review of efficacy of radiofrequency ablation for treatment of colorectal cancer liver metastases from a Canadian perspective.
Kwan BY; Kielar AZ; El-Maraghi RH; Garcia LM
Can Assoc Radiol J; 2014 Feb; 65(1):77-85. PubMed ID: 22867961
[TBL] [Abstract][Full Text] [Related]
51. Local Treatment of Breast Cancer Liver Metastasis.
Bale R; Putzer D; Schullian P
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31514362
[TBL] [Abstract][Full Text] [Related]
52. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
[TBL] [Abstract][Full Text] [Related]
53. Effect of colorectal resection combined with intraoperative radiofrequency ablation in treating colorectal cancer with liver metastasis and analysis of its prognosis.
Fu T; He L; Liu F
J BUON; 2020; 25(5):2171-2179. PubMed ID: 33277832
[TBL] [Abstract][Full Text] [Related]
54. Radiofrequency ablation versus traditional liver resection and chemotherapy for liver metastases from gastric cancer.
Tang K; Zhang B; Dong L; Wang L; Tang Z
J Int Med Res; 2020 Jul; 48(7):300060520940509. PubMed ID: 32687001
[TBL] [Abstract][Full Text] [Related]
55. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
56. Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer.
Franzese C; Comito T; Viganò L; Pedicini V; Franceschini D; Clerici E; Loi M; Donadon M; Poretti D; Solbiati L; Torzilli G; Scorsetti M
Clin Breast Cancer; 2020 Dec; 20(6):480-486. PubMed ID: 32631769
[TBL] [Abstract][Full Text] [Related]
57. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinoma.
Du YQ; Bai XM; Yang W; Zhang ZY; Wang S; Wu W; Yan K; Chen MH
Int J Hyperthermia; 2022; 39(1):517-524. PubMed ID: 35311422
[TBL] [Abstract][Full Text] [Related]
58. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
59. Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation.
Guner A; Son T; Cho I; Kwon IG; An JY; Kim HI; Cheong JH; Noh SH; Hyung WJ
Gastric Cancer; 2016 Jul; 19(3):951-60. PubMed ID: 26231353
[TBL] [Abstract][Full Text] [Related]
60. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
Wang CZ; Yan GX; Xin H; Liu ZY
World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
